During the last session, Apogee Therapeutics Inc (NASDAQ:APGE)’s traded shares were 0.42 million, with the beta value of the company hitting 1.78. At the end of the trading day, the stock’s price was $39.72, reflecting an intraday gain of 1.20% or $0.47. The 52-week high for the APGE share is $69.40, that puts it down -74.72 from that peak though still a striking 26.74% gain since the share price plummeted to a 52-week low of $29.10. The company’s market capitalization is $2.36B, and the average intraday trading volume over the past 10 days was 0.67 million shares, and the average trade volume was 623.09K shares over the past three months.
Apogee Therapeutics Inc (NASDAQ:APGE) trade information
Apogee Therapeutics Inc (APGE) registered a 1.20% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.20% in intraday trading to $39.72, hitting a weekly high. The stock’s 5-day price performance is -0.30%, and it has moved by 30.10% in 30 days. Based on these gigs, the overall price performance for the year is -39.57%. The short interest in Apogee Therapeutics Inc (NASDAQ:APGE) is 8.16 million shares and it means that shorts have 10.72 day(s) to cover.
The consensus price target of analysts on Wall Street is $95, which implies an increase of 58.19% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $95 and $95 respectively. As a result, APGE is trading at a discount of -139.17% off the target high and -139.17% off the low.
While earnings are projected to return -56.75% in 2025, the next five years will return -22.96% per annum.
APGE Dividends
Apogee Therapeutics Inc is due to release its next quarterly earnings on 2025-Mar-02. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Apogee Therapeutics Inc (NASDAQ:APGE)’s Major holders
Apogee Therapeutics Inc insiders own 11.36% of total outstanding shares while institutional holders control 130.16%, with the float percentage being 146.85%. VR ADVISER, LLC is the largest shareholder of the company, while 232.0 institutions own stock in it. As of 2024-06-30, the company held over 8.49 million shares (or 15.0284% of all shares), a total value of $334.21 million in shares.
The next largest institutional holding, with 7.51 million shares, is of FMR LLC’s that is approximately 13.2812% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $295.36 million.
Also, the Mutual Funds coming in first place with the largest holdings of Apogee Therapeutics Inc (APGE) shares are VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund . Data provided on Oct 31, 2024 indicates that VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund owns about 2.0 shares. This amounts to just over 4.44 percent of the company’s overall shares, with a $79.44 million market value. The same data shows that the other fund manager holds slightly less at 1.41, or about 3.12% of the stock, which is worth about $55.86 million.
